The Food and Drug Administration (FDA) is planning a public meeting to solicit feedback on agencywide data strategy modernization scheduled for March 27.

According to an announcement in the Jan. 8 Federal Register, the meeting will center on new approaches to data quality, stewardship, exchange, and analytics. More specifically, FDA seeks comments around three topic areas: standards and policy; data security, privacy, and management; and data strategies and data sharing.

The agency wrote that a strategic approach to data is an important angle of its Technology Modernization Action Plan to provide a foundation for “a more fluid, agile, and efficient FDA.”

“FDA intends to develop a modernized agency-wide, strategic approach not only to technology, but to data itself,” the announcement states. “Data is at the heart of FDA’s work as a science-based agency, and we anticipate ongoing, rapid increases in the amount and complexity of the data that informs FDA’s regulatory decision-making process and how we advance our public health mission.”

Individuals interested in presenting or becoming a panelist at the public meeting should apply by Jan. 28. The meeting will be webcast for those unable to attend.

The agency is also accepting written comments through April 30.

Read More About
More Topics
Katie Malone
Katie Malone
Katie Malone is a MeriTalk Staff Reporter covering the intersection of government and technology.